missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Reagenzien für die Proteinanalyse
  4. Bioaktive kleine Moleküle
  5. R&D Systems™ (R)-(-)-α-Methylhistamine dihydrobromide

R&D Systems™ (R)-(-)-α-Methylhistamine dihydrobromide

Artikelnummer. 30001101
Ansicht ändern
Click to view available options
Menge:
10 mg
50 mg
Packungsgröße:
10 Milligramm
50 Milligramm
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Menge Packungsgröße
30001101 10 mg 10 Milligramm
18006052 50 mg 50 Milligramm
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen
Artikelnummer. 30001101 Lieferant R&D Systems™ Lieferanten-Nr. 0569/10

This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
 Alternative Produkte anzeigen

missing translation for 'validMainframeMsg'

Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

Beschreibung

A Tocris product, part of R&D Systems. Potent, standard H3 agonist

Very potent, high affinity H3 agonist (KD = 50.3 nM) that displays > 200-fold selectivity over H4 receptors. Inhibits H3-mediated histamine synthesis and release in the CNS and stimulates H4-mediated eosinophil shape change (EC50 = 66 nM).

S-enantiomer also available.

TRUSTED_SUSTAINABILITY

Chemische Identifikatoren

CAS 868698-49-1
Summenformel C6H13Br2N3

Spezifikation

Chemischer Name oder Material (R)-(-)-α-Methylhistamine dihydrobromide
Menge 10 mg
Produktlinie Tocris
Formelmasse 287
Reinheit >99%
Molekulargewicht 286.999
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.